Financial
Personal
Pluristyx Announces Immediate Availability of GMP-Compliant PSXi013 iPSC Line for Advanced Therapy Development
Revolutionary iPSC line poised to accelerate development of groundbreaking treatments SEATTLE — Pluristyx, a leading provider of Good Manufacturing Practices (GMP), cutting-edge, induced pluripotent stem cell (iPSC) technologies, today announce
Revolutionary iPSC line poised to accelerate development of groundbreaking treatments Read More